Inhibikase Therapeutics News

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Werner Milton H.

Apr 4 04:51

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lees-Rolfe Garth

Apr 3 05:17

Inhibikase Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lees-Rolfe Garth

Apr 3 05:17

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BERMAN DENNIS N

Jul 6, 2023 09:18

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dion Gisele

Jul 6, 2023 09:16

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GRINT PAUL C

Jul 6, 2023 09:12

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Freeman Roy Lester

Jul 6, 2023 09:11

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Werner Milton H.

Mar 4, 2023 06:00

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer FRATTAROLI JOSEPH

Mar 4, 2023 06:00

Inhibikase Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-FiveT Investment Management Ltd(4.78%),FiveT Capital AG(4.78%)

Feb 25, 2023 01:27

Inhibikase Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Milton H. Werner(19.68%)

Feb 16, 2023 08:45

Inhibikase Therapeutics | D: Filing D

Feb 8, 2023 05:48

Inhibikase Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-FiveT Investment Management Ltd(4.12%),FiveT Capital AG(4.12%)

Feb 1, 2023 00:59

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Sep 7, 2022 05:08

Inhibikase Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Dion Gisele

Sep 7, 2022 05:06

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Aug 17, 2022 04:25

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jun 29, 2022 09:00

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jun 29, 2022 09:00

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jun 29, 2022 09:00

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities

Jun 29, 2022 09:00